Munafa Stock Market Course + Intraday & FNO calls 
Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)
Technical Analysis Report for NASDAQ stock OTLK Outlook Therapeutics. Dated: 16 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics
Outlook Therapeutics Opened at 0.29 and Closed at: 0.27, which is 0% of previous session's close. It moved within a range of 0.26 and 0.29
The session was a Bearish session with an average volume of 2231679, which is -24.97% of previous session's volumes.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 0.25 and resistance for tomorrow is 0.28
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.26, 0.24 resistance for tomorrow's hourly charts is 0.29, 0.3
10 Day SMA for Outlook Therapeutics (OTLK) is 0.24 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Outlook Therapeutics (OTLK) is 0.24 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Outlook Therapeutics (OTLK) is 0.35 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.83 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Outlook Therapeutics is 1.2 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Outlook Therapeutics is at 0.24 and 200 DMA is at 1.2, while 50 DMA and 100 DMA are at 0.35 and 0.83 respectively
Outlook Therapeutics (OTLK) moving average of 20 SMA is at 0.24 and 20 EMA is at 0.27
| Date | Closing Price | 20 SMA | 20 EMA |
| 16 Thu Apr | 0.27 | 0.24 | 0.27 |
| 15 Wed Apr | 0.27 | 0.25 | 0.27 |
| 14 Tue Apr | 0.25 | 0.25 | 0.27 |
| 13 Mon Apr | 0.25 | 0.26 | 0.27 |
| 10 Fri Apr | 0.25 | 0.27 | 0.27 |
| 09 Thu Apr | 0.22 | 0.28 | 0.27 |
Outlook Therapeutics (OTLK) moving average of 50 SMA is at 0.35 and 50 EMA is at 0.41
| Date | Closing Price | 50 SMA | 50 EMA |
| 16 Thu Apr | 0.27 | 0.35 | 0.41 |
| 15 Wed Apr | 0.27 | 0.35 | 0.42 |
| 14 Tue Apr | 0.25 | 0.36 | 0.43 |
| 13 Mon Apr | 0.25 | 0.36 | 0.44 |
| 10 Fri Apr | 0.25 | 0.37 | 0.45 |
| 09 Thu Apr | 0.22 | 0.37 | 0.46 |
Outlook Therapeutics (OTLK) moving average of 100 SMA is at 0.83 and 100 EMA is at 0.73
| Date | Closing Price | 100 SMA | 100 EMA |
| 16 Thu Apr | 0.27 | 0.83 | 0.73 |
| 15 Wed Apr | 0.27 | 0.85 | 0.74 |
| 14 Tue Apr | 0.25 | 0.87 | 0.75 |
| 13 Mon Apr | 0.25 | 0.88 | 0.76 |
| 10 Fri Apr | 0.25 | 0.9 | 0.77 |
| 09 Thu Apr | 0.22 | 0.91 | 0.78 |
Outlook Therapeutics (OTLK) moving average of 200 SMA is at 1.2 and 200 EMA is at 1.26
| Date | Closing Price | 200 SMA | 200 EMA |
| 16 Thu Apr | 0.27 | 1.2 | 1.26 |
| 15 Wed Apr | 0.27 | 1.21 | 1.27 |
| 14 Tue Apr | 0.25 | 1.22 | 1.28 |
| 13 Mon Apr | 0.25 | 1.23 | 1.29 |
| 10 Fri Apr | 0.25 | 1.23 | 1.3 |
| 09 Thu Apr | 0.22 | 1.24 | 1.31 |
Xeris Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 30.27% more returns!
Xbiotech Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Xbiotech Inc, about 23.12% more returns!
Savara Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Savara Inc, about 29.89% more returns!
Phio Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 26.42% more returns!
Intellia Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 28.19% more returns!
Neurocrine Biosciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 19.6% more returns!
Ligand Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Ligand Pharmaceuticals, about 26.57% more returns!
Acadia Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 23.2% more returns!
Aldeyra Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 18.42% more returns!
Amarin Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Amarin Corporation, about 18.33% more returns!
Apyx Medical has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 33.48% more returns!
Alphatec Holdings has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Alphatec Holdings, about 5.59% more returns!
Editas Medicine has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Editas Medicine, about 62.96% more returns!
Exelixis Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Exelixis Inc, about 28.15% more returns!
Galapagos Nv has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Galapagos Nv, about 9.04% more returns!
Incyte Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 23.23% more returns!
Iradimed Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 12.38% more returns!
Jazz Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Jazz Pharmaceuticals, about 29.38% more returns!
Outlook Therapeutics Technical analysis of indicators
Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Outlook Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Outlook Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.24 and Outlook Therapeutics OTLK stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.
Outlook Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And OTLK Experts View which covers a lot of information including buying and selling signals
OTLK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
